• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子可导致人体通气-灌注不匹配。

Platelet-activating factor causes ventilation-perfusion mismatch in humans.

作者信息

Rodriguez-Roisin R, Félez M A, Chung K F, Barberà J A, Wagner P D, Cobos A, Barnes P J, Roca J

机构信息

Servei de Pneumologia i Al.lèrgia Respiratòria, Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain.

出版信息

J Clin Invest. 1994 Jan;93(1):188-94. doi: 10.1172/JCI116944.

DOI:10.1172/JCI116944
PMID:8282786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC293752/
Abstract

We hypothesized that platelet-activating factor (PAF), a potent inflammatory mediator, could induce gas exchange abnormalities in normal humans. To this end, the effect of aerosolized PAF (2 mg/ml solution; 24 micrograms) on ventilation-perfusion (VA/Q) relationships, hemodynamics, and resistance of the respiratory system was studied in 14 healthy, nonatopic, and nonsmoking individuals (23 +/- 1 [SEM]yr) before and at 2, 4, 6, 8, 15, and 45 min after inhalation, and compared to that of inhaled lyso-PAF in 10 other healthy individuals (24 +/- 2 yr). PAF induced, compared to lyso-PAF, immediate leukopenia (P < 0.001) followed by a rebound leukocytosis (P < 0.002), increased minute ventilation (P < 0.05) and resistance of the respiratory system (P < 0.01), and decreased systemic arterial pressure (P < 0.05). Similarly, compared to lyso-PAF, PaO2 showed a trend to fall (by 12.2 +/- 4.3 mmHg, mean +/- SEM maximum change from baseline), and arterial-alveolar O2 gradient increased (by 16.7 +/- 4.3 mmHg) (P < 0.02) after PAF, because of VA/Q mismatch: the dispersion of pulmonary blood flow and that of ventilation increased by 0.45 +/- 0.1 (P < 0.01) and 0.29 +/- 0.1 (P < 0.04), respectively. We conclude that in normal subjects, inhaled PAF results in considerable immediate VA/Q inequality and gas exchange impairment. These results reinforce the notion that PAF may play a major role as a mediator of inflammation in the human lung.

摘要

我们推测,强效炎症介质血小板活化因子(PAF)可在正常人体内诱发气体交换异常。为此,我们对14名健康、无特应性且不吸烟的个体(23±1[标准误]岁)在吸入雾化PAF(2mg/ml溶液;24μg)前以及吸入后2、4、6、8、15和45分钟时的通气-灌注(VA/Q)关系、血流动力学和呼吸系统阻力进行了研究,并与另外10名健康个体(24±2岁)吸入溶血PAF后的情况进行了比较。与溶血PAF相比,PAF诱发了即刻白细胞减少(P<0.001),随后出现白细胞增多反弹(P<0.002),增加了分钟通气量(P<0.05)和呼吸系统阻力(P<0.01),并降低了体循环动脉压(P<0.05)。同样,与溶血PAF相比,PAF吸入后,由于VA/Q不匹配,PaO2呈下降趋势(从基线最大变化为12.2±4.3mmHg,均值±标准误),动脉-肺泡氧梯度增加(16.7±4.3mmHg)(P<0.02):肺血流和通气的离散度分别增加了0.45±0.1(P<0.01)和0.29±0.1(P<0.04)。我们得出结论,在正常受试者中,吸入PAF会导致相当程度的即刻VA/Q不均等和气体交换受损。这些结果强化了PAF可能在人类肺部炎症介导中起主要作用这一观点。

相似文献

1
Platelet-activating factor causes ventilation-perfusion mismatch in humans.血小板活化因子可导致人体通气-灌注不匹配。
J Clin Invest. 1994 Jan;93(1):188-94. doi: 10.1172/JCI116944.
2
Salbutamol inhibits pulmonary effects of platelet activating factor in man.
Am J Respir Crit Care Med. 1995 Jun;151(6):1740-4. doi: 10.1164/ajrccm.151.6.7767515.
3
Inhaled platelet-activating factor worsens gas exchange in mild asthma.
Am J Respir Crit Care Med. 1994 Aug;150(2):369-73. doi: 10.1164/ajrccm.150.2.8049817.
4
The effects of 5-lipoxygenase inhibition by zileuton on platelet-activating-factor-induced pulmonary abnormalities in mild asthma.
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1559-64. doi: 10.1164/ajrccm.157.5.9711088.
5
Inhibition of PAF-induced gas exchange defects by beta-adrenergic agonists in mild asthma is not due to bronchodilation.β-肾上腺素能激动剂对轻度哮喘中PAF诱导的气体交换缺陷的抑制作用并非源于支气管扩张。
Am J Respir Crit Care Med. 1997 Jul;156(1):17-22. doi: 10.1164/ajrccm.156.1.9610100.
6
Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study.急性哮喘中对血小板活化因子受体拮抗剂SR 27417A的气体交换反应:一项初步研究。
Eur Respir J. 1999 Sep;14(3):622-6. doi: 10.1034/j.1399-3003.1999.14c23.x.
7
Platelet-activating factor and bacteremia-induced pulmonary hypertension.血小板活化因子与菌血症诱导的肺动脉高压
J Surg Res. 2000 Feb;88(2):173-80. doi: 10.1006/jsre.1999.5748.
8
Lack of systemic oxidative stress during PAF challenge in mild asthma.轻度哮喘患者在PAF激发过程中缺乏全身性氧化应激。
Respir Med. 2005 May;99(5):519-23. doi: 10.1016/j.rmed.2004.10.013. Epub 2004 Nov 21.
9
The effect of inhalation of platelet-activating factor on the pulmonary clearance of 99mTc-DTPA aerosol.
Am J Respir Crit Care Med. 1995 May;151(5):1621-4. doi: 10.1164/ajrccm.151.5.7735622.
10
Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Relationship to bronchoconstriction and changes in airway responsiveness.
Am Rev Respir Dis. 1990 Feb;141(2):386-92. doi: 10.1164/ajrccm/141.2.386.

引用本文的文献

1
Pathophysiology of food-induced anaphylaxis.食物诱导的过敏反应的病理生理学
Curr Allergy Asthma Rep. 2008 May;8(3):201-8. doi: 10.1007/s11882-008-0034-6.
2
Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.血小板活化因子作为支气管哮喘的一种介质及治疗手段。
Inflammation. 2008 Apr;31(2):112-20. doi: 10.1007/s10753-007-9056-9. Epub 2008 Jan 12.
3
Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor.

本文引用的文献

1
Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.乙酰甘油醚磷酸胆碱(一种兔IgE过敏反应介质)引起的呼吸和循环系统改变。
Am Rev Respir Dis. 1980 Dec;122(6):915-24. doi: 10.1164/arrd.1980.122.6.915.
2
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.血小板活化因子增加肺微血管通透性并诱发肺水肿。初步报告。
Bull Eur Physiopathol Respir. 1983 May-Jun;19(3):253-6.
3
Inert gas analysis of ventilation-perfusion matching during hemodialysis.
血小板活化因子通过与其功能性受体结合发挥促有丝分裂活性并刺激人肺成纤维细胞中白细胞介素6和白细胞介素8的表达。
J Exp Med. 1996 Jul 1;184(1):191-201. doi: 10.1084/jem.184.1.191.
4
Contributions of multiple inert gas elimination technique to pulmonary medicine.3. Bronchial asthma.多种惰性气体消除技术对肺病学的贡献。3. 支气管哮喘。
Thorax. 1994 Oct;49(10):1027-33. doi: 10.1136/thx.49.10.1027.
血液透析期间通气-灌注匹配的惰性气体分析
J Clin Invest. 1984 May;73(5):1385-91. doi: 10.1172/JCI111342.
4
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine.乙酰甘油醚磷酸胆碱诱导血管通透性增加的形态学基础
Lab Invest. 1984 Jan;50(1):16-25.
5
Acute effects of intratracheal administration of platelet-activating factor in baboons.气管内给予狒狒血小板活化因子的急性效应。
J Appl Physiol Respir Environ Exerc Physiol. 1983 Sep;55(3):799-804. doi: 10.1152/jappl.1983.55.3.799.
6
The mechanisms of arterial hypoxemia during hemodialysis.血液透析期间动脉血氧不足的机制。
Am Rev Respir Dis. 1984 May;129(5):780-4. doi: 10.1164/arrd.1984.129.5.780.
7
Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).用1-O-十六烷基/十八烷基-2-乙酰基-sn-甘油-3-磷酸胆碱(血小板活化因子)激活人中性粒细胞。
J Immunol. 1981 Sep;127(3):1250-5.
8
Measurement of continuous distributions of ventilation-perfusion ratios: theory.通气-灌注比连续分布的测量:理论
J Appl Physiol. 1974 May;36(5):588-99. doi: 10.1152/jappl.1974.36.5.588.
9
Platelet-activating factor increases lung vascular permeability to protein.血小板活化因子可增加肺血管对蛋白质的通透性。
J Appl Physiol (1985). 1986 Dec;61(6):2210-7. doi: 10.1152/jappl.1986.61.6.2210.
10
Pulmonary vascular response to platelet-activating factor in awake sheep and the role of cyclooxygenase metabolites.清醒绵羊肺血管对血小板活化因子的反应及环氧化酶代谢产物的作用。
Am Rev Respir Dis. 1986 Sep;134(3):548-54. doi: 10.1164/arrd.1986.134.3.548.